BAX Baxter International
$25.41 on 2026-10-28 · $13.1B · +38.7%
Baxter International is a large cap Health Care company in Health Care Equipment. At $25.41 a share the market values it at $13.1 billion, up 39% over the past year.
Is BAX undervalued? Six plain tests
The rule asks what Buffett-style investors ask, using only Baxter International’s own SEC filings: is it worth more than its price (upside of 20% or more to model value), is it a good business (a quality score of 0.5 or more), does it really make money (profits and positive cash earnings), and can it carry its debt (net debt under 3.5× operating income)?
It also skips cyclicals at peak margins, where today’s profits flatter the price. Read the method in plain English, exactly how each number is calculated, or why a margin of safety matters.
Other Health Care companies
- RVTYRevvity
- ZBHZimmer Biomet
- CRLCharles River Laboratories
- SOLVSolventum
- DVADaVita
- TECHBio-Techne
- COOCooper Companies (The)
- ALGNAlign Technology
Who owns BAX? Funds managing over $100M report their US holdings every quarter on Form 13F. See the latest 13F filings as they land on SEC EDGAR.
Research only, not investment advice. Figures come from BAX’s SEC filings (trailing twelve months to 2026-06-30) and daily closes.